Three hours of jogging or 13 of walking per week: according to a U.S. study moderate exercise reduces the risk of breast cancer Being fit, as we know, is not only an aesthetic issue. And now it seems that it is also useful for the prevention of breast cancer. A study of about 65,000 women by researchers at Washington University School of Medicine in St.. Louis and from Harvard University in Boston, just published in Journal of the National Cancer Institute, points out that women practicing sports have a 23 per cent lower risk of developing cancer before the menopause. In particular, it may be important to regularly exercise between the ages of 12 and 22 years. "We have prevention strategies for breast cancer pre-menopausal, but our research shows that physical activity during adolescence and youth, between 12 and 35 years, may be important in the long term reduction of the risk of cancer", said Graham Colditz, professor of Prevention and Control and co-director at the Siteman Cancer Center, Washington University School of Medicine and Barnes-Jewish Hospital. "This is just one more reason to encourage young women to exercise regularly."

Satb1 controls the expression of genes that control the growth of tumour mass and the formation of metastases. The discovery in Nature magazine. It is a protein the cause of the aggressiveness of breast cancer. It's called Satb1 and was already known to scientists involved because expression of T cells of the immune system. Only now it has revealed its darkest side, showing that they play a key role in the malignant form of breast cancer. Metastases, which are formed when cells are adding themselves to the tumour to invade tissues nearby and colonize other parts of the body, represent the advanced stage of the disease. Researchers have now discovered that the cells of the breast cancer need their protein Satb1 to become metastatic. The study has just been published in Nature.

A study analysis conducted over the past 27 years by British researchers, suggests that some Fans can reduce the risk of developing cancer. A review of studies published over the last 27 years suggests that the anti-inflammatory non-steroidal pharmacy drugs (Fans) such as aspirin could reduce the risk of breast cancer by as much as 20 per cent! In support, some experts of Guy's Hospital in London appeared in a publication of International Journal of Clinical Practice. According to Ian Fentiman, Fans could play an important role not only in prevention, but also as a therapy for women who have developed this type of cancer, combining their use with a hormonal treatment and using them as analgesics.